Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -257.10% is 79% below its 5-year average of -143.88%, near the low end of its 5-year range (-744.43%–4457.32%).
11.43% above its 12-month average of -290.27%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -144.20%.
NET PROFIT MARGIN
-257.10%
NET PROFIT MARGIN AVG TTM
-290.27%
NET PROFIT MARGIN AVG 3Y
-163.02%
NET PROFIT MARGIN AVG 5Y
-143.88%
NET PROFIT MARGIN AVG 10Y
-89.78%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+11.43%
CURRENT VS 3Y AVG
-57.71%
CURRENT VS 5Y AVG
-78.70%
CURRENT VS 10Y AVG
-186.37%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 644 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Coherus Oncology, Inc.
Market Cap
$164.54M
Net Profit Margin
-257.10%
TTM Avg
-290.27%
3Y Avg
-163.02%
5Y Avg
-143.88%
Market Cap
$168.13M
Net Profit Margin
4.66%
TTM Avg
-8.57%
3Y Avg
-15.00%
5Y Avg
-10.75%
Market Cap
$170.49M
Net Profit Margin
-19.76%
TTM Avg
3.38%
3Y Avg
2.83%
5Y Avg
6.10%
Market Cap
$156.56M
Net Profit Margin
-6.94%
TTM Avg
-8.61%
3Y Avg
-17.97%
5Y Avg
-12.59%
Market Cap
$172.77M
Net Profit Margin
-170.10%
TTM Avg
-145.13%
3Y Avg
-100.04%
5Y Avg
-83.24%
Market Cap
$173.20M
Net Profit Margin
-117.04%
TTM Avg
-61.51%
3Y Avg
-173.42%
5Y Avg
-194.84%
Market Cap
$155.86M
Net Profit Margin
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$155.61M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.79%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | $164.54M | -257.10% | -290.27% | -163.02% | -143.88% |
| OptimizeRx Corp. (OPRX)vs › | $168.13M | 4.66% | -8.57% | -15.00% | -10.75% |
| Organogenesis Holdings Inc. (ORGO)vs › | $170.49M | -19.76% | 3.38% | 2.83% | 6.10% |
| Inogen, Inc. (INGN)vs › | $156.56M | -6.94% | -8.61% | -17.97% | -12.59% |
| MediWound Ltd. (MDWD)vs › | $172.77M | -170.10% | -145.13% | -100.04% | -83.24% |
| Nkarta, Inc. (NKTX)vs › | $172.78M | 0.00% | 0.00% | 0.00% | 0.00% |
| Precision BioSciences, Inc. (DTIL)vs › | $173.20M | -117.04% | -61.51% | -173.42% | -194.84% |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $155.86M | N/A | 0.00% | 0.00% | 0.00% |
| Minerva Neurosciences, Inc. (NERV)vs › | $155.61M | 0.00% | 0.00% | 0.00% | 0.79% |
| LifeMD, Inc. (LFMDP)vs › | $154.72M | -10.40% | -6.28% | -16.07% | -47.85% |
Operating Margin
-425.7%
Net Profit Margin
-257.1%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -144.20% |
| 2026-03-31 | -308.20% |
| 2025-12-31 | -292.42% |
| 2025-09-30 | -303.42% |
| 2025-06-30 | -403.11% |
| 2025-03-31 | -744.43% |
| 2024-12-31 | -93.63% |
| 2024-09-30 | -15.19% |
| 2024-06-30 | -19.88% |
| 2024-03-31 | 4457.32% |
| 2023-12-31 | -87.03% |
| 2023-09-30 | -53.16% |
| 2023-06-30 | -73.01% |
| 2023-03-31 | -233.47% |
| 2022-12-31 | -129.81% |
| 2022-09-30 | -190.76% |
| 2022-06-30 | -83.37% |
| 2022-03-31 | -159.83% |
| 2021-12-31 | -62.32% |
| 2021-09-30 | -46.70% |
| 2021-06-30 | -34.12% |
| 2021-03-31 | -208.28% |
| 2020-12-31 | 8.79% |
| 2020-09-30 | 24.60% |
| 2020-06-30 | 43.51% |
| 2020-03-31 | 30.62% |
| 2019-12-31 | 31.67% |
| 2019-09-30 | 42.12% |
| 2019-06-30 | 28.25% |
| 2019-03-31 | -53.92% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | -3966.74% |
| 2017-03-31 | -46445.96% |
| 2016-12-31 | -8995.38% |
| 2016-09-30 | 51.55% |
| 2016-06-30 | -497.35% |
| 2016-03-31 | -529.07% |
| 2015-12-31 | -513.74% |
| 2015-09-30 | -995.31% |
| 2015-06-30 | -856.54% |
| 2015-03-31 | -700.95% |
| 2014-12-31 | -448.70% |
| 2014-09-30 | -49.04% |
| 2014-06-30 | -502.66% |
| 2014-03-31 | -699.94% |
| 2013-12-31 | -1184.33% |
| 2013-09-30 | -4243.68% |
| 2013-06-30 | -1717.75% |
| 2013-03-31 | -1751.38% |
